Jyotsna Mehta

996 total citations
25 papers, 712 citations indexed

About

Jyotsna Mehta is a scholar working on Hematology, Epidemiology and Genetics. According to data from OpenAlex, Jyotsna Mehta has authored 25 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Jyotsna Mehta's work include Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jyotsna Mehta is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jyotsna Mehta collaborates with scholars based in United States, New Zealand and France. Jyotsna Mehta's co-authors include Michael A. Fischer, William H. Shrank, Emily R. Cox, Niteesh K. Choudhry, Jerry Avorn, Sebastian Schneeweiß, Wolfgang C. Winkelmayer­, Colin R. Dormuth, Amanda R. Patrick and Daniel H. Solomon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Jyotsna Mehta

22 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyotsna Mehta United States 11 277 151 112 84 67 25 712
Kathleen McElhone United Kingdom 21 237 0.9× 179 1.2× 103 0.9× 94 1.1× 52 0.8× 39 1.9k
Alan K. Matsumoto United States 13 58 0.2× 73 0.5× 29 0.3× 34 0.4× 65 1.0× 18 675
Michel Lamure France 15 190 0.7× 46 0.3× 20 0.2× 94 1.1× 65 1.0× 54 715
Zaina P. Qureshi United States 13 82 0.3× 93 0.6× 35 0.3× 42 0.5× 50 0.7× 47 630
Márcio Machado Canada 15 141 0.5× 102 0.7× 17 0.2× 53 0.6× 41 0.6× 23 905
Anthony Matthews Sweden 16 102 0.4× 56 0.4× 15 0.1× 127 1.5× 85 1.3× 44 1.1k
Alexandre Vivot France 14 127 0.5× 61 0.4× 26 0.2× 56 0.7× 78 1.2× 29 745
K Weiss United States 9 78 0.3× 60 0.4× 11 0.1× 52 0.6× 40 0.6× 14 661
Zaixing Shi United States 15 31 0.1× 96 0.6× 54 0.5× 59 0.7× 113 1.7× 33 915
Hua Lu China 14 39 0.1× 55 0.4× 65 0.6× 54 0.6× 61 0.9× 61 705

Countries citing papers authored by Jyotsna Mehta

Since Specialization
Citations

This map shows the geographic impact of Jyotsna Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyotsna Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyotsna Mehta more than expected).

Fields of papers citing papers by Jyotsna Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyotsna Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyotsna Mehta. The network helps show where Jyotsna Mehta may publish in the future.

Co-authorship network of co-authors of Jyotsna Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Jyotsna Mehta. A scholar is included among the top collaborators of Jyotsna Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyotsna Mehta. Jyotsna Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dirven, Hubert, Gunn Elisabeth Vist, Sricharan Bandhakavi, et al.. (2021). Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review. Scientific Reports. 11(1). 6403–6403. 44 indexed citations
3.
Gould, Ian, et al.. (2020). <p>US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma</p>. ClinicoEconomics and Outcomes Research. Volume 12. 317–325. 5 indexed citations
4.
Breeze, John, Jyotsna Mehta, Gabriel Tremblay, et al.. (2020). PCN324 MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) FOR THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY - MULTIPLE MYELOMA (FACT-MM): TWO APPROACHES. Value in Health. 23. S81–S81. 1 indexed citations
5.
Breeze, Janis L., Jyotsna Mehta, Gabriel Tremblay, et al.. (2020). PCN304 QUALITY OF LIFE ANALYSES IN PATIENTS WITH MULTIPLE MYELOMA: RESULTS FROM THE SELINEXOR (KPT-330) TREATMENT OF REFRACTORY MYELOMA (STORM) PHASE 2B STUDY. Value in Health. 23. S77–S77. 1 indexed citations
6.
Jagannath, Sundar, Jyotsna Mehta, Janis L. Breeze, et al.. (2020). Quality-of-life (QOL) analyses in patients with multiple myeloma: Results from the selinexor (KPT-330) treatment of refractory myeloma (STORM) phase IIb study.. Journal of Clinical Oncology. 38(15_suppl). e20522–e20522. 3 indexed citations
7.
Mehta, Jyotsna, et al.. (2020). PCN135 UTILITY VALUES IN PATIENTS WITH RR MULTIPLE MYELOMA - A SYSTEMATIC LITERATURE REVIEW. Value in Health. 23. S47–S47.
8.
Tsaioun, Katya, Jyotsna Mehta, & Hubert Dirven. (2018). Evidence-based methodology for identifying drugs with potential human liver toxicities using WHO Vigibase data. Figshare. 1 indexed citations
9.
Mehta, Jyotsna, Hongwei Wang, Jon P. Fryzek, Sheikh Usman Iqbal, & Ruben A. Mesa. (2014). Health resource utilization and cost associated with myeloproliferative neoplasms in a large United States health plan. Leukemia & lymphoma. 55(10). 2368–2374. 23 indexed citations
10.
Mehta, Jyotsna, Edward E. Walsh, Parthiv J. Mahadevia, & Ann R. Falsey. (2013). Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 10(3). 293–299. 50 indexed citations
11.
Schneeweiß, Sebastian, Amanda R. Patrick, Daniel H. Solomon, et al.. (2010). Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in Adults. Archives of General Psychiatry. 67(5). 497–497. 53 indexed citations
12.
Lin, Nancy D., Ken Kleinman, K. Arnold Chan, et al.. (2010). Multiple vaccinations and the risk of medically attended fever. Vaccine. 28(25). 4169–4174. 1 indexed citations
13.
Schneeweiß, Sebastian, Amanda R. Patrick, Daniel H. Solomon, et al.. (2010). Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts. PEDIATRICS. 125(5). 876–888. 63 indexed citations
14.
Shrank, William H., Suzanne M. Cadarette, Emily R. Cox, et al.. (2009). Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization?. Medical Care. 47(3). 319–325. 73 indexed citations
15.
Shrank, William H., Emily R. Cox, Michael A. Fischer, Jyotsna Mehta, & Niteesh K. Choudhry. (2009). Patients’ Perceptions Of Generic Medications. Health Affairs. 28(2). 546–556. 207 indexed citations
16.
Brookhart, M. Alan, Sebastian Schneeweiß, Jerry Avorn, et al.. (2008). The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD. Journal of the American Society of Nephrology. 19(7). 1389–1395. 57 indexed citations
17.
Agnew‐Blais, Jessica, Jonathan S. Coblyn, Jeffrey N. Katz, et al.. (2008). Measuring quality of care for rheumatic diseases using an electronic medical record. Annals of the Rheumatic Diseases. 68(5). 680–684. 22 indexed citations
18.
Mehta, Jyotsna, et al.. (2007). Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney International. 72(11). 1388–1393. 51 indexed citations
19.
Winkelmayer­, Wolfgang C., Jyotsna Mehta, Anil Chandraker, William F. Owen, & Jerry Avorn. (2007). Predialysis Nephrologist Care and Access to Kidney Transplantation in the United States. American Journal of Transplantation. 7(4). 872–879. 43 indexed citations
20.
Kulkarni, Sanjeev R., R Powles, Seema Singhal, et al.. (1998). Second cancers and non-autologous bone marrow transplantation for haematological malignancies: Single centre experience of 883 patients.. Queensland's institutional digital repository (The University of Queensland). 21(10). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen McElhone Breakdown of academic impact, for papers by Alan K. Matsumoto Breakdown of academic impact, for papers by Michel Lamure Breakdown of academic impact, for papers by Zaina P. Qureshi Breakdown of academic impact, for papers by Márcio Machado Breakdown of academic impact, for papers by Anthony Matthews Breakdown of academic impact, for papers by Alexandre Vivot Breakdown of academic impact, for papers by K Weiss Breakdown of academic impact, for papers by Zaixing Shi Breakdown of academic impact, for papers by Hua Lu
Rankless by CCL
2026